ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,714,730, issued on Aug. 25, was assigned to PERSEPHONE BIOSCIENCES (San Diego).
"Compositions for modulating gut microflora populations, enhancing drug potency and treating cancer, and methods for making and using same" was invented by Stephanie J. Culler (Del Mar, Calif.), Robert J. Haselbeck (San Diego), Steven Van Dien (San Diego) and Anandh Swaminathan (San Diego).
According to the abstract* released by the U.S. Patent & Trademark Office: "In alternative embodiments, provided are compositions, including products of manufacture and kits, and methods, for or comprising administering to an individual in need thereof an inhibitor of an inhibitory immune checkpoint molecule and/or a s...